Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Role of Myo-inositol and D-chiro-inositol on Oocyte Quality

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01338844
Recruitment Status : Completed
First Posted : April 20, 2011
Last Update Posted : June 1, 2011
Sponsor:
Collaborators:
Research Center for Reproductive Medicine Villa Mafalda
San Raffaele University Hospital, Italy
Information provided by:
AGUNCO Obstetrics and Gynecology Centre

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Controlled ovarian hyperstimulation with gonadotropins is an integral part of the various stimulation protocols for patients undergoing in-vitro fertilization (IVF) and other Assisted Reproductive Technologies (ART) such as intracytoplasmic sperm injection (ICSI).

The hormonal control of multiple follicular growth and maturation is a critical part of ART procedures since it maximizes the yield of embryos to be transferred, thus increasing the cumulative pregnancy rate.

Recent studies have shown the efficacy of myo-inositol (MI) supplementation as a simple and highly effective treatment in order to improve oocyte quality in patients undergoing IVF. Indeed, it was previously shown that MI follicular fluid (FF) concentration is a reliable predictor of oocyte quality. High MI concentration in the FF directly correlates with high oocyte and embryo quality.

Another stereoisomer of Inositol was successfully used into clinical practice D-chiro-inositol (DCI). In particular, DCI supplementation was used to restore ovulation in hyperglycemic PCOS patients.

In the present study we aim to compare MI versus DCI supplementation on oocyte quality of women undergoing IVF-ET


Condition or disease Intervention/treatment Phase
Infertility Dietary Supplement: Myo-inositol Dietary Supplement: D-chito-Inositol Phase 4

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Official Title: A Prospective, Randomized, Double Blind, Study on the Clinical Efficacy Myo-inositol Versus D-chiro-inositol in Women Undergoing in Vitro Fertilization Embryo Transfer.

Resource links provided by the National Library of Medicine

Drug Information available for: Inositol

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: D-Chiro-inositol
Patients will receive 1.2g/day of D-chiro-inositol
 Dietary Supplement: D-chito-Inositol
Active Comparator: Myo-inositol
Patients will receive 4g/day of myo-inositol
 Dietary Supplement: Myo-inositol


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. number of morphologically mature oocytes
  2. Total international units (IU) of recombinant FSH administrated
  3. number of grade 1 embryos

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • women undergoing IVF treatments
  • Body mass index <28
  • FSH <10IU/L
  • Normal uterine cavity, anatomy and functions

Exclusion Criteria:

  • PCOS
  • Stage III or IV endometriosis
  • Premature ovarian failure
  • Poor responder
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01338844


Locations
Layout table for location information
Italy
San Raffaele Hospital
Milan, Italy
Research Center for Reproductive Medicine Villa Mafalda
Roma, Italy
Agunco
Rome, Italy
Sponsors and Collaborators
AGUNCO Obstetrics and Gynecology Centre
Research Center for Reproductive Medicine Villa Mafalda
San Raffaele University Hospital, Italy
Investigators
Layout table for investigator information
Principal Investigator: Gianfranco Carlomagno, Ph.D. AGUNCO Obstetrics and Gynecology Centre
Principal Investigator: Vittorio Unfer, M.D. AGUNCO Obstetrics and Gynecology Centre
Principal Investigator: Franco Lisi, M.D. Research Center for Reproductive Medicine
Principal Investigator: Enrico Papaleo, M.D. San Raffaele Hospital
Principal Investigator: Scott Roseff, MD The Palm Beach Center for Reproductive Medicine
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:

Layout table for additonal information
ClinicalTrials.gov Identifier: NCT01338844    
Other Study ID Numbers: MI_vs_DCI_Oo_q
First Posted: April 20, 2011    Key Record Dates
Last Update Posted: June 1, 2011
Last Verified: April 2011
Keywords provided by AGUNCO Obstetrics and Gynecology Centre:
Poor oocyte quality
IVF failure
Additional relevant MeSH terms:
Layout table for MeSH terms
Infertility
Inositol
Vitamin B Complex
 Vitamins
Micronutrients
Physiological Effects of Drugs